Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05737706
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-02-10
Brief Title:
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Organization Data
Organization:
Mirati Therapeutics Inc
Class:
INDUSTRY
Study ID:
CA246-0005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mirati Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None